English  |  正體中文  |  简体中文  |  Total items :0  
Visitors :  52604685    Online Users :  817
Project Commissioned by the Ministry of Education
Project Executed by National Taiwan University Library
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
About TAIR

Browse By

News

Copyright

Related Links

"hsu c s"

Return to Browse by Author
Sorting by Title Sort by Date

Showing items 61-110 of 309  (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-09-04T06:12:26Z Factors affecting early viral load decline of Asian chronic hepatitis C patients receiving pegylated interferon plus ribavirin therapy Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Esomeprazole for asthma [7] Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:24Z Capsule endoscopy versus colonoscopy Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:23Z Both insulin resistance and alanine aminotransferase level increase the risks of cardiovascular disease in fatty liver disease Hsu C.-S.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:23Z Peginterferon alfa-2b or alfa-2a with ribavirin for hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Outcomes of HCV treatment: Who does well and who does not? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:22Z Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Hsu C.-S.; Liu C.-H.; Liu C.-J.; Hsu S.-J.; Chen C.-L.; Hwang J.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:21Z Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: A ten-year observation Huang Z.-S.; Huang T.-S.; Wu T.-H.; Chen M.-F.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:20Z Hepatitis C infection and metabolic syndrome. Hsu C.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection Hsu C.-S.; Wang C.-C.; Wang P.-C.; Lin H.H.; Tseng T.-C.; Chen C.-H.; Su W.-C.; Liu C.-J.; Chen C.-L.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:18Z Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B Su T.-H.; Hsu C.-S.; Chen C.-L.; Liu C.-H.; Huang Y.-W.; Tseng T.-C.; Liu C.-J.; Chen P.-J.; Lai M.-Y.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:16Z Use of statins and gallstone risk [1] Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:11Z Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan Mah Y.-H.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:11Z Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy Tseng T.-C.; Yu M.-L.; Liu C.-J.; Lin C.-L.; Huang Y.-W.; Hsu C.-S.; Liu C.-H.; Kuo S.F.-T.; Pan C.J.-H.; Yang S.-S.; Su C.-W.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:10Z HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection Hsu S.-J.; Hsu C.-S.; Liu C.-H.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:08Z Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Tseng T.-C.; Liu C.-H.; Niu W.-F.; Jeng J.; Liu C.-J.; Lai M.-Y.; Chen P.-J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:07Z Reply to Guedj et al.: Early transient increase of hepatitis C virus viral load in genotype 1 and 2 infections, and the use of mathematical modeling Hsu C.-S.; Chen H.-C.; Jeng J.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:12:07Z Boceprevir for chronic HCV genotype 1 infection [2] Hsu, C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:05Z Alpha-fetoprotein in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:04Z Hepatitis C virus and lipid profiles: More questions than answers? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:12:01Z Impact of hepatitis B virus infection on metabolic profiles and modifying factors Hsu C.-S.; Liu C.-H.; Wang C.-C.; Tseng T.-C.; Liu C.-J.; Chen C.-L.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:59Z Management of hepatitis C virus infection in the genomic era Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:58Z Severity of fatty liver on ultrasound correlates with metabolic and cardiovascular risk Wang C.-C.; Tseng T.-C.; Hsieh T.-C.; Hsu C.-S.; Wang P.-C.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Genomic variation-guided management in chronic hepatitis C Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:56Z Non-alcoholic fatty liver disease: An emerging liver disease in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:55Z Advances in the treatment of chronic hepatitis C: From interferon to direct acting anti-virals Liu C.-J.; Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Fluvastatin helps interferon-based therapy in chronic hepatitis C: Fact or fiction? Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:54Z Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir Wang C.-C.; Tseng K.-C.; Peng C.-Y.; Hsieh T.-Y.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Hsu C.-S.; Lin H.H.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:53Z IL-21R gene polymorphisms and serum IL-21 levels predict virological response to interferon-based therapy in Asian chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen C.-L.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:50Z Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients Hsu C.-S.; Hsu S.-J.; Chen H.-C.; Liu C.-H.; Jeng J.; Liu C.-J.; Chen P.-J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:46Z Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: A population-based cohort study in Taiwan Hsu C.-S.; JIA-HORNG KAO; Chao Y.-C.; Lin H.H.; Fan Y.-C.; Huang C.-J.; Tsai P.-S.
臺大學術典藏 2021-09-04T06:11:46Z Interferon-Based Therapy Decreases Risks of Hepatocellular Carcinoma and Complications of Cirrhosis in Chronic Hepatitis C Patients Hsu C.-S.; Huang C.-J.; JIA-HORNG KAO; Lin H.H.; Chao Y.-C.; Fan Y.-C.; Tsai P.-S.
臺大學術典藏 2021-09-04T06:11:43Z Factors affecting the diagnostic accuracy of ultrasonography in assessing the severity of hepatic steatosis Wang C.-C.; Hsieh T.-C.; Tseng T.-C.; Wang P.-C.; Hsu C.-S.; Lin H.H.; Wang L.-Y.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:38Z A pilot study of add-on oral hypoglycemic agents in treatment-na?ve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin Hsu C.-S.; Hsu S.-J.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:28Z Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection Hsu C.-S.; Liu W.-L.; Chao Y.-C.; Lin H.H.; Tseng T.-C.; Wang C.-C.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:26Z Systematic review: Impact of interferon-based therapy on HCV-related hepatocellular carcinoma Hsu C.-S.; Chao Y.-C.; Lin H.H.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:19Z HIV/HCV coinfection in Taiwan Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:15Z Management of hepatitis C patients with decompensated liver disease Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:13Z Association of SCARB1 Gene Polymorphisms with Virological Response in Chronic Hepatitis C Patients Receiving Pegylated Interferon plus Ribavirin Therapy Hsu C.-S.; Hsu S.-J.; Liu W.-L.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T06:11:07Z Pegylated IFN-α suppresses hepatitis C virus by promoting the DAPK-mTOR pathway Liu W.-L.; Yang H.-C.; Hsu C.-S.; Wang C.-C.; Wang T.-S.; JIA-HORNG KAO; Chen D.-S.
臺大學術典藏 2021-09-04T06:11:00Z An update on non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in Asia Hsu C.S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:58Z Sarcopenia and chronic liver diseases Hsu C.-S.; JIA-HORNG KAO
臺大學術典藏 2021-09-04T05:16:31Z Hepatitis C virus genotypes 1–3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes Hsu C.-S.; Liu W.-L.; Li Q.; Lowey B.; Hertz L.; Chao Y.-C.; Liang T.J.; Chen D.-S.; JIA-HORNG KAO
臺大學術典藏 2021-08-03T01:43:27Z Integrated Surface Modification to Enhance the Luminescence Properties of K2TiF6:Mn4+ Phosphor and Its Application in White-Light-Emitting Diodes Fang M.-H;Hsu C.-S;Su C;Liu W;Wang Y.-H;Liu R.-S.; Fang M.-H; Hsu C.-S; Su C; Liu W; Wang Y.-H; Liu R.-S.; RU-SHI LIU
臺大學術典藏 2021-08-03T01:42:59Z A Universal Approach for Controllable Synthesis of n-Specific Layered 2D Perovskite Nanoplates Lin J.-T;Chen D.-G;Wu C.-H;Hsu C.-S;Chien C.-Y;Chen H.-M;Chou P.-T;Chiu C.-W.; Lin J.-T; Chen D.-G; Wu C.-H; Hsu C.-S; Chien C.-Y; Chen H.-M; Chou P.-T; Chiu C.-W.; HAO MING CHEN
臺大學術典藏 2021-08-03T01:42:58Z Comprehensively Probing the Contribution of Site Activity and Population of Active Sites toward Heterogeneous Electrocatalysis Chen H.-C;Chen T.-L;Lin S.-C;Hsu C.-S;Chan T.-S;Liao M.-Y;Chen H.M.; Chen H.-C; Chen T.-L; Lin S.-C; Hsu C.-S; Chan T.-S; Liao M.-Y; Chen H.M.; HAO MING CHEN
臺大學術典藏 2021-08-03T01:42:57Z Electronic structure inspired a highly robust electrocatalyst for the oxygen-evolution reaction Zhang P;Lu Y.-R;Hsu C.-S;Xue H.-G;Chan T.-S;Suen N.-T;Chen H.M.; Zhang P; Lu Y.-R; Hsu C.-S; Xue H.-G; Chan T.-S; Suen N.-T; Chen H.M.; HAO MING CHEN
臺大學術典藏 2021-08-03T01:42:55Z In Situ Identifying the Dynamic Structure behind Activity of Atomically Dispersed Platinum Catalyst toward Hydrogen Evolution Reaction Wang J;Tan H.-Y;Kuo T.-R;Lin S.-C;Hsu C.-S;Zhu Y;Chu Y.-C;Chen T.L;Lee J.-F;Chen H.M.; Wang J; Tan H.-Y; Kuo T.-R; Lin S.-C; Hsu C.-S; Zhu Y; Chu Y.-C; Chen T.L; Lee J.-F; Chen H.M.; HAO MING CHEN
臺大學術典藏 2021-08-03T01:42:54Z Mechanism of Oxygen Evolution Catalyzed by Cobalt Oxyhydroxide: Cobalt Superoxide Species as a Key Intermediate and Dioxygen Release as a Rate-Determining Step Moysiadou A;Lee S;Hsu C.-S;Chen H.M;Hu X.; Moysiadou A; Lee S; Hsu C.-S; Chen H.M; Hu X.; HAO MING CHEN
臺大學術典藏 2021-08-03T01:42:53Z Product-Specific Active Site Motifs of Cu for Electrochemical CO2 Reduction Zhu C;Zhang Z;Zhong L;Hsu C.-S;Xu X;Li Y;Zhao S;Chen S;Yu J;Chen S;Wu M;Gao P;Li S;Chen H.M;Liu K;Zhang L.; Zhu C; HAO MING CHEN et al.

Showing items 61-110 of 309  (7 Page(s) Totally)
<< < 1 2 3 4 5 6 7 > >>
View [10|25|50] records per page